Revati Shreeniwas, M.D.

Clinical Development Advisor

Dr. Revati Shreeniwas has over twenty years of clinical and drug development experience and has held positions of increasing responsibility as Director, Clinical Research at CV Therapeutics, and Senior Director, Clinical Research and Development at Actelion Inc, and Scios, a subsidiary of Johnson and Johnson. Dr. Shreeniwas was President of Revati, Inc., a consulting group where she was responsible for providing strategic consulting to life sciences companies. Dr. Shreeniwas has also served on the faculties of Columbia University and Stanford University.

J. Mark Fitzgerald, M.D.

Scientific Advisor

Dr. J. Mark FitzGerald is a Consultant Respiratory Physician at The Lung Centre, Vancouver General Hospital, and Professor of Medicine and head of the UBC Respiratory Medicine program at the University of British Columbia. He is the founding Director of the UBC Centre for Lung Health and co-Director of the newly formed Institute for Heart and Lung Health at UBC. He has an extensive program of clinical research in asthma, COPD, tuberculosis, and health outcomes. He has worked with national and international groups to develop evidence based asthma guidelines. He is a member of the CTS Executive and it’s Asthma Committee and has worked with the Canadian Asthma Guidelines working group since 1989. He is a member of the Global Initiative in Asthma (GINA), Executive, and Chair of its Science Committee. He has published over 280 peer reviewed papers and editorials.

Stefan Dalberg, B.Eng.

Device Engineering Advisor

Stefan has extensive fabrication and experience with a background in fluid dynamics and composite fabrication. Currently, he is the lead composite technician and a principle investigator with Sports and Wellness Engineering Technology for Applied Research at the Southern Alberta Institute of Technology. He specializes in prototype design, manufacturing, and product design, testing, and analysis as well as 3D scanning rapid prototyping (3D printing).